Mixed-Flow Fans Meet Biosafety Level Laboratory Requirements - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Mixed-Flow Fans Meet Biosafety Level Laboratory Requirements
Mixed-flow impeller systems exhaust laboratory workstation fume hoods, prevent reentrainment into the facility and adjacent facilities, and help companies comply with appropriate pollution-control standards.


Pharmaceutical Technology


The air from within the BSC is exhausted through a high-efficiency particulate air (HEPA) filter, either into the laboratory or more commonly to the outside. Mixed-flow impeller fans can discharge the exhaust air well above the building rooflines to eliminate the possibility of reentrainment, regardless of wind and atmospheric conditions.

Furthermore, many BSL facilities use animals for research, which often creates odor problems. Although such odors are not a direct health hazard, they may be a significant nuisance. Dilution of the odiferous exhaust with ambient air and discharge of the resulting stream high into the atmosphere by a mixed-flow fan can be an efficient odor-management strategy. Iowa State University's College of Veterinary Medicine is very active with infectious disease research work. When it upgraded a BSL-2 laboratory to meet BSL-3 requirements, facility management was concerned that the existing centrifugal fans (one dedicated exhaust fan system and roof-mounted stack for each workstation) would not adequately eliminate the possibility of exhaust reentrainment and prevent toxic, noxious, or odiferous workstation exhaust from escaping into the neighborhood.


Figure 2 (FIGURES ARE COURTESY OF THE AUTHOR)
To address these concerns, Iowa State installed a mixed-flow impeller exhaust system (see Figure 2). George Mellen, the engineer in charge of mechanical and electrical design, cited two major factors in this decision: "First, we wanted to get the room and biological safety cabinet exhaust plumes up high enough so that there was no chance of it being ingested with other makeup air systems (reentrainment prevention), and, second, mixed-flow impeller technology allows us the opportunity in the future to install heat-recovery systems which should decrease heating costs."

Saving energy through heat recovery

Most BSL research laboratories require 100% conditioned makeup air because workstation exhaust cannot be reintroduced into the building. The makeup air must be filtered, heated or cooled, humidified or dehumidified, and so forth, depending on the circumstances. This process significantly increases energy costs—to as high as $6/ft3 solely for conditioning the makeup air.

Energy consumption in mixed-flow systems is about 25% lower than with conventional centrifugal fans. A typical energy reduction is $0.44/cfm at $0.10/kWh. This translates to a return on investment of approximately two years.


Figure 3 (FIGURES ARE COURTESY OF THE AUTHOR)
A mixed-flow impeller exhaust system with integral heat recovery can cut energy costs by reducing the consumption of natural gas, oil, or electricity. These devices, as shown in Figure 3, consist of a heat exchanger containing coils filled with a glycolsolution that extracts ambient energy from the workstation fume hood exhaust before it is discharged. The glycol–water solution is transferred to the supply-air handler to preheat the conditioned air entering the building during winter or pre-cool the air during summer.

A typical system will reduce heating costs about 3% for each 1 F of makeup-air preheat that is added. A 10 F increase in intake-air temperature translates directly into a 30% energy saving, which could amount to considerable savings. Similar savings would be realized for cooling.

When the University of Richmond upgraded its biology, chemistry, and physics laboratories in its science center, it installed two separate and independent mixed-flow impeller systems. The renovation expanded the total laboratory space being ventilated by more than 20,000 ft2, yet the school did not need to increase its energy budget as a result of the added system.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: Pharmaceutical Technology,
Click here